• Home 
  • General Presentation 
    • What's irib?
    • Composition
  • Research Laboratories 
    • CIC-CRB 1404 - Clinical Research Centre - Biological Resources Center  
      • Research Topics
      • Composition
      • Facilities
      • Activity
      • Main Contributions
      • Main Publications
    • Inserm Unit U1096 - Endothelium, Valvulopathy & Heart Failure (EnVI)  
      • Research Topics
      • Composition
      • Facilities
      • Activity
      • Main Contributions
      • Main Publications
    • Inserm Unit U1073 - Digestive Tract Environment and Nutrition   
      • Research Topics
      • Composition
      • Facilities
      • Activity
      • Main Contributions
      • Main Publications
    • Inserm Unit U1234 - Pathophysiology, Autoimmunity, Neuromuscular diseases and regenerative THERapies (PANTHER)  
      • Research Topics
      • Composition
      • Facilities
      • Activity
      • Main Contributions
      • Main Publications
    • Inserm Unit U1239 - Neuronal and Neuroendocrine Differenciation and Communication  
      • Research Topics
      • Composition
      • Facilities
      • Activity
      • Main Contributions
      • Main Publications
    • Inserm Unit U1245 - Genomic and Personalized Medicine in Cancer and Neurological disorders  
      • Research Topics
      • Composition
      • Facilities
      • Activity
      • Main Contributions
      • Main Publications
    • Research Team EA 2656 - Research group on antimicrobial agents and microorganisms  
      • Research Topics
      • Composition
      • Facilities
      • Activity
      • Main Contributions
      • Main Publications
    • Research Team EA 3830  - Ventilary Handicap Research Group  
      • Research Topics
      • Composition
      • Facilities
      • Activity
      • Main Contributions
      • Main Publications
    • Research Team EA 4108 - Data Processing in Biology & Health (LITIS)  
      • Research Topics
      • Composition
      • Facilities
      • Activity
      • Main Contributions
      • Main Publications
    • Research Team EA 4108 - Quantif Medical Imaging Group (LITIS)  
      • Research Topics
      • Composition
      • Facilities
      • Activity
      • Main Contributions
      • Main Publications
    • Research Team EA 4308  - Gametogenesis and gamete quality  
      • Research Topics
      • Composition
      • Facilities
      • Activity
      • Main Contributions
      • Main Publications
    • Research Team EA 4312 - Laboratory of Microbiology Signals and Microenvironment  
      • Research Topics
      • Composition
      • Facilities
      • Activity
      • Main Contributions
      • Main Publications
    • Research Team EA 4358 - Glycobiology and Plant Extracellular Matrix  
      • Research Topics
      • Composition
      • Facilities
      • Activity
      • Main Contributions
      • Main Publications
    • Research Team EA 7510 ESCAPE - Foodborne protozoan diseases  
      • Research Topics
      • Composition
      • Facilities
      • Activity
      • Main Contributions
      • Main Publications
    • Research Unit UMR6014 - Organic and Bioorganic Chemistry, Reactivity, Analysis  
      • Research Topics
      • Composition
      • Facilities
      • Activity
      • Main Contributions
      • Main Publications
    • Research Unit UMR6270 - Polymers, Biopolymers, Surfaces, Biofilm Resistance, Cell-Surface Interactions group  
      • Research Topics
      • Composition
      • Facilities
      • Activity
      • Main Contributions
      • Main Publications
  • Facilities 
    • Behavioral Analysis Facility  
      • Research Topics
      • Composition
      • Facilities
      • Activity
      • Main Contributions
      • Main Publications
    • Cell Imaging platform of Normandy  
      • Research Topics
      • Composition
      • Facilities
      • Activity
      • Main Contributions
      • Main Publications
    • Evaluation of oxidative stress  
      • Research Topics
      • Composition
      • Facilities
      • Activity
      • Main Contributions
      • Main Publications
    • Flow Cytometry and Cell Analysis Facility  
      • Research Topics
      • Composition
      • Facilities
      • Activity
      • Main Contributions
      • Main Publications
    • Genomic Analysis Facility  
      • Research Topics
      • Composition
      • Facilities
      • Activity
      • Main Contributions
      • Main Publications
    • Nuclear Magnetic Resonance Spectroscopy Facility  
      • Research Topics
      • Composition
      • Facilities
      • Activity
      • Main Contributions
      • Main Publications
    • Proteomic Facility  
      • Research Topics
      • Composition
      • Facilities
      • Activity
      • Main Contributions
      • Main Publications
    • Small Animal Magnetic Resonance Imaging Facility  
      • Research Topics
      • Composition
      • Facilities
      • Activity
      • Main Contributions
      • Main Publications
  • Publications
  • Letters
  • Yearly Meetings  
    • 2019/11/19 - JNRB2019 - Pôle de Formation et de Recherche en Santé de Caen  
    • 2018/09/20 - JNRB 2018 -Batiment Stewart UFR Santé Rouen  
    • 2017/11/14 - Caen  
    • 2016/09/16 - Rouen UFR Médecine Pharmacie  
    • 2015/06/05 - Rouen UFR Médecine Pharmacie  
    • 2014/06/20 - Manoir Henri IV de Caugé (Agglomération d'Evreux)  
    • 2013/06/21 - Maison de l'Université Rouen  

Research Laboratories

CIC-CRB 1404



Clinical Research Centre - Biological Resources Center


Head


Pr. Anne-Marie Leroi - Dr. Marie-Pierre Tavolacci - Dr. Eglantine Ferrand Devouge - Dr. Muriel Quillard-Muraine


Contact


Centre d'Investigation Clinique CHU de Rouen
1 rue de Germont
76031 Rouen cedex
Phone: +33 232 88 8862
secretariat.CIC@chu-rouen.fr
anne-marie.leroi@chu-rouen.fr  

https://www.chu-rouen.fr/service/centre-dinvestigation-clinique/


Research Topics


TYPES OF RESEARCH
  • Biomedical drug research: 56 % (mainly phase II and III clinical trials)
  • Physiological studies: 22 %
  • Genetic studies: 5 %
  • Medical devices: 8 %
  • Cohort studies: 9 %

FIELDS OF RESEARCH
  • Cardiovascular, Nutrition, Digestive System Disease: 11 %
  • Neurosciences, Neurology: 26 %
  • Genetics, Cancer, Immunology: 21 %
  • Diagnostic and therapeutic innovation: 42 %



Composition


·         45 researchers, engineers, technicians

·         1 Quality referent, 1 Biostatistician, 1 Lawyer

 




Facilities


 
  • Coordinator Site (CIC-CRB 1404):
    • CIC 1404:
      • Site Authorization for Healthy Volunteer Trials
      • File of 1500 healthy volunteers
      • Methodological support
      • 3 clinical trials dedicated beds with 3 scopes
      • 2 ECG
      • 1 defibrillator
      • Main access to functionnal imaging and exploration
    • Biological Resources Centre
      • Impedancemeter
      • 7 Ultra Low Temperature Freezer (-80°C)
      • 4 Ultra Low Temperature Freezer (-20°C)
      • Laboratory centrifuges
      • Main access to Tumour banks (Federation of Pathology CRLCC-CHU)
  • Endocrinology and Diabetology Site (U 1239):
    • Ultra Low Temperature Freezer (-80°C).
    • Ultra Low Temperature Freezer (-20°C)
    • Laboratory centrifuges
  • Neurology Site (U 1245 & U 1073):
    • Main access to diseases biomarkers
    • Functionnal imaging and exploration (MRI 3T).
    • PET imaging
    • CSF biomarkers
    • Neurosurgical team with expertise in deep brain neurostimulation
    • Site Authorization for Healthy Volunteer Trials
    • 2 polysomnography and 2 multiparameter recorders
  • Nutrition Site (U 1073):
    • Body composition through DEXA or bio-impedancemeter
    • Bone Densitometry
    • Calorimeter
    • Mass spectrometric analysis and in vivo isotopic studies
  • Pediatrics Site (U 1239):
    • Ultra Low Temperature Freezer (-20°C)
    • Laboratory centrifuges
  • Pharmacology Site (U 1096):
    • Clinical vascular imaging (echo-tracking, tonometry)
    • Site Authorization for Healthy Volunteer Trials
  • Physiology Site (U 1073):
    • Digestive function investigation platform (manometry, barostat, electrophysiological studies, breath tests, gastric emptying, impedancemetry, sphincter planimetry..)
    • Digestive Neurostimulation
    • Magnetic transcranial stimulation
    • Site Authorization for Healthy Volunteer Trials
  • Pneumology Site (EA 4108):
    • In vivo confocal endomicroscopy (Cellvizio®)
  • Rheumatology Site (U 1234):
    • Ultrasonography
    • Bone mineral densitometry
    • Ultra Low Temperature Freezer (-80°C).
    • 6 Ultra Low Temperature Freezer (-20°C)
    • Laboratory centrifuges.
    • Access to radiology department
  • Urology Site:
    • Surgical robot
    • Koelis system (prostate targeted biopsies)
    • Hexvix Fluorescence (bladder cancer)
    • Chemotherapy Unit with access to immunotherapy and antiangiogenic therapies



Activity


The Clinical Investigation Centre (Inserm-CIC 1404) and Biological Resources Centre is an ambulatory care and hospitalization Centre dedicated to clinical trials. It includes a coordinating site and 9 clinical sites (see table). The CIC-CRB 1404 was labeled in 2002, recently renewed in 2016. Research taking place in the Centre covers all medical and surgical specialties.
All types of studies are concerned: phases I to IV clinical trials, evaluation of medical devices,
epidemiological, physiological and diagnostic studies. Technical resources also benefit from other several associated units facilities present within the Departments of epidemiology, Physiology, Pneumology, Endocrinology, Neurology, Nutrition, Pharmacology, Rheumatology, Urology and Pediatrics of the University hospital. The mission of the CIC-CRB 1404 is to provide facilities and resources (staff, methodology, equipment….) to researchers performing clinical studies. The CIC-CRB 1404 especially promotes translational research based on close interactions between scientists and physicians of the medical campus. Our objective is to produce new scientific and medical knowledge while ensuring compliance with ethical and legal requirements.
The CIC-CRB 1404 also participates in the training and teaching of clinical research: Master “Methods in Clinical Pharmacology and Training in Therapeutic Trials” and D.I.U. Investigator in Biomedical Research.


Main Contributions


From 2010 to 2015, 255 research protocols:
  • Institutional (65%);
  • private pharmaceutical companies (35%).



Main Publications


2018

  • Patout M, Sesé L, Gille T, Coiffard B, Korzeniewski S, Lhuillier E, Pradel A, Tardif C, Chambellan A, , Straus C, , Matecki S, Perez T, , Thiberville L, and Didier A. Does training respiratory physicians in clinical respiratory physiology and interpretation of pulmonary function tests improve core knowledge. Thorax 2018, 73: 78-81.
    28258249
  • Pulido M, Roubaud G, Cazeau AL, Mahammedi H, Vedrine L, Joly F, Mourey L, Pfister C, Goberna A, Lortal B, Bellera C, Pourquier P and Houédé N. Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancer. BMC Cancer 2018, 18: 194.
    29454321
  • Wils J, Djerada Z, Roca F, Duflot T, Iacob M, Remy-Jouet I, Joannides R and Bellien J. Alteration in the availability of epoxyeicosatrienoic acids contributes with NO to the development of endothelial dysfunction in conduit arteries during aging. Atherosclerosis 2018, 275: 239-245.
    29980050

2017

  • Achamrah N, Coëffier M, Rimbert A, Charles J, Folope V, Petit A, Déchelotte P and Grigioni S. Micronutrient Status in 153 Patients with Anorexia Nervosa. Nutrients 2017, 9:  E225.
    28257095
  • Boyer O, Bridoux V, Giverne C, Bisson A, Koning E, Leroi AM, Chambon P, Déhayes J, Le Corre S, Jacquot S, Bastit D, Martinet J, Houivet E, Tuech JJ, Benichou J and Michot F; and the Study Group of Myoblast Therapy for Faecal Incontinence. Autologous Myoblasts for the Treatment of Fecal Incontinence: Results of a Phase 2 Randomized Placebo-controlled Study (MIAS). Ann Surg 2017
    28426476
  • Brito-Zerón P, Acar-Denizli N, Zeher M, Rasmussen A, Seror R, Theander E, Li X, Baldini C, Gottenberg JE, Danda D, Quartuccio L, Priori R, Hernandez-Molina G, Kruize AA, Valim V, Kvarnstrom M, Sene D, Gerli R, Praprotnik S, Isenberg D, Solans R, Rischmueller M, Kwok SK, Nordmark G, Suzuki Y, Giacomelli R, Devauchelle-Pensec V, Bombardieri M, Hofauer B, Bootsma H, Brun JG, Fraile G, Carsons SE, Gheita TA, Morel J, Vollenveider C, Atzeni F, Retamozo S, Horvath IF, Sivils K, Mandl T, Sandhya P, De Vita S, Sanchez-Guerrero J, van der Heijden E, Trevisani VFM, Wahren-Herlenius M, Mariette X and Ramos-Casals M,; EULAR-SS Task Force Big Data Consortium. Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium. Ann Rheum Dis 2017, 76: 1042-1050.
    27899373
  • Marie I, Gehanno JF, Bubenheim M, Duval-Modeste AB, Joly P, Dominique S, Bravard P, Noël D, Cailleux AF, Benichou J, Levesque H and Goullé JP. Systemic sclerosis and exposure to heavy metals: A case control study of 100 patients and 300 controls. Autoimmun Rev 2017, 16: 223-230.
    28137480
  • Mas JL, Derumeaux G, Guillon B, Massardier E, Hosseini H, Mechtouff L, Arquizan C, Béjot Y, Vuillier F, Detante O, Guidoux C, Canaple S, Vaduva C, Dequatre-Ponchelle N, Sibon I, Garnier P, Ferrier A, Timsit S, Robinet-Borgomano E, Sablot D, Lacour JC, Zuber M, Favrole P, Pinel JF, Apoil M, Reiner P, Lefebvre C, Guérin P, Piot C, Rossi R, Dubois-Randé JL, Eicher JC, Meneveau N, Lusson JR, Bertrand B, Schleich JM, Godart F, Thambo JB, Leborgne L, Michel P, Pierard L, Turc G, Barthelet M, Charles-Nelson A, Weimar C, Moulin T, Juliard JM and Chatellier G; CLOSE Investigators. Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke. N Engl J Med 2017, 377: 1011-1021.
    28902593
  • Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M and Matthews DR; CANVAS Program Collaborative Group. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes. N Engl J Med 2017, 377: 644-657.
    28605608
  • Saguintaah M, Cabon Y, Gauthier R, Duboibaudry C, Couderc L, Le Bourgeois M, Reix P, Chiron R, Arrada IT, Molinari N and Matecki S. A simplified, semi-quantitative structural lung disease computed tomography outcome during quiet breathing in infants with cystic fibrosis. J Cyst Fibros 2017, 16: 151-157.
    27888005

Lettre de l'IRIB - avril 2021

La Lettre de l’IRIB du mois de avril 2021 (n°76) est en ligne.

Pour consulter les archives, merci de cliquer ici

Lettre de l'IRIB - Janvier 2021

La Lettre de l’IRIB du mois de janvier 2021 (n°75) est en ligne.

Pour consulter les archives, merci de cliquer ici

Lettre de l'IRIB - Décembre 2020

La Lettre de l’IRIB du mois de décembre 2020 (n°74) est en ligne.

Pour consulter les archives, merci de cliquer ici

Lettre de l'IRIB - Octobre 2020

La Lettre de l’IRIB du mois de octobre 2020 (n°73) est en ligne.

Pour consulter les archives, merci de cliquer ici

LATEST NEWS    ARCHIVE



Events


Connexion


Newsletter


CONTACT US
logo
IRIB Normandy Rouen
22 Boulevard Gambetta
76183 ROUEN Cedex
France

Direction
contact@irib-normandy.fr

Secretariat
secretariat@irib-normandy.fr

logo logo
Design by Alexis Lebon © IRIB Normandy Rouen, 2012 - All rights reserved.